Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Enlibrium

Enlibrium?uq=w9if130k
2015 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$15M LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer of novel drugs designed to treat a range of different cancers. The company's novel drugs are based on metformin that reduces cancer energy consumption and reestablishes energy balance.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • San Diego, CA
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Enlibrium’s full profile, request a free trial.

Enlibrium Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 03-Dec-2015 $15M 0000 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Enlibrium Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00 00.0 00.0 00 00.0 000
To view this company’s complete Cap Table, request access »

Enlibrium Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Avalon Ventures Venture Capital Minority 000 0000 000000 0
Correlation Ventures Venture Capital Minority 000 0000 000000 0
Osage University Partners Venture Capital Minority 000 0000 000000 0
TPG Biotech Corporate Venture Capital Minority 000 0000 000000 0

Enlibrium Executive Team (3)

Name Title Board
Seat
Contact
Info
Michael Jung Ph.D Co-Founder
Richard Pietras Ph.D Co-Founder
David Campbell Ph.D President & Chief Executive Officer

Enlibrium Board Members (2)

Name Representing Role Since Contact
Info
Heather Preston MD TPG Biotech Board Member 000 0000
Jay Lichter Ph.D Avalon Ventures Board Member 000 0000